IAI Announces Medical Assist ELECYLINDER Series

 

April 1, 2021

IAI (Intelligent Actuator Incorporated) would like to introduce their ELECYLINDER® electric actuator series.

The main features are easy operation, AVD (acceleration/speed/deceleration) that can be adjusted individually, and high performance. Due to its stable quality, it is ideal for the manufacturing industry of medical products where product accuracy is required.

Here is an example of how the smooth operation of ELECYLINDER® improved a packaging application. Previously, an air cylinder was used to transfer accepted products. To achieve a shorter cycle time, the air cylinder was operated at a high speed but gave a big shock at the time of the stoppage. As a result, some temporary stops took place in the post-process due to the dispersion of transferred positions of accepted products. Since the ELECYLINDER can adjust acceleration/deceleration, there is no shock even at a high-speed operation. As a result, the dispersion of the transferred positions was eliminated, reducing temporary stops and shortening the cycle time.

ELECYLINDER® makes it easy to adjust and control AVD (A: Acceleration, V: Speed, D: Deceleration), allowing packages to move smoothly between conveyors positioned at right angles without affecting internal products. In addition, ELECYLINDER® has a wide range of products available for many types of applications.

“IAI is proud to be at the forefront of technology that supports the medical community in the fight against disease and future health crises,” said Kaz Haruna, National Sales Manager at IAI America.

IAI is actively assisting the medical community by providing Cartesian and SCARA robots for infectious disease testing, molecular diagnostics, tissue and blood sampling, genomic research, cancer research, pharmaceuticals, and medical device production. It is IAI’s hope that our ELECYLINDER® Series will help the medical/pharmaceutical industries move ahead with advanced innovation.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.